A round of Series C funding raised $126 million for Chinese molecular diagnostics company Burning Rock. It intends to use the proceeds to fund development of early cancer detection products and to expand its companion diagnostics sales and marketing force.
Funding round brings in $126M for Burning Rock
Sign up for AABB SmartBrief
News about transfusion and cellular therapies
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.